G-CSF-mobilized haploidentical peripheral blood stem cell transplantation in children with poor prognostic nonmalignant disorders

American Journal of Hematology

Volumn 83, Issue 2, 2008, Pages 133-136

  Arpaci, Fikret ^a   Tezcan, Ilhan ^b   Kuzhan, Okan ^a   Yalman, Nevin ^c   Uçkan, Duygu ^b   Kürekçi, Ahmet Emin ^a   Ikincioǧullari, Aydan ^d   Özet, Ahmet ^a   Tanyeli, Atilla ^e  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c Istanbul Bizim Losemili Cocuklar Vakfi (Istanbul Foundation for Our Children with Leukemia)   (Turkey)

^d ANKARA UNIVERSITY   (Turkey)

^e CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

APLASTIC ANEMIA; ARTICLE; CD34 SELECTION; CLINICAL ARTICLE; ENGRAFTMENT; FEMALE; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HAPLOIDENTICAL PERIPHERAL BLOOD STEM CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNOMAGNETIC BEAD DEPLETION DEVICE; IMMUNOMAGNETIC SEPARATION; INFANT; LEUKAPHERESIS; LEUKOCYTE; LUNG INFECTION; MALE; MORTALITY; OSTEOPOROSIS; PERIPHERAL BLOOD STEM CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SAFETY; SEVERE COMBINED IMMUNODEFICIENCY; STEM CELL MOBILIZATION; SURVIVAL RATE; T CELL DEPLETION; T LYMPHOCYTE; THROMBOCYTE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ANEMIA, APLASTIC; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT SURVIVAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; INFANT; LYMPHOCYTE DEPLETION; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROGNOSIS; SEVERE COMBINED IMMUNODEFICIENCY; TREATMENT OUTCOME;

EID: 38349139834     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21017     Document Type: Article

References (25)

1. Reisner Y, Kapoor N, Kirkpatrick D, et al. Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractioned by soybean agglutinin and sheep red blood cells. Blood 1983;61:341-348.
2. Buckley RH, Schiff SE, Schiff RI, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999;340:508-516.
3. Antoine C, Muller S, Cant A, et al. European Group for Blood and Marrow Transplantation; European Society for Immunodeficiency. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: Report of European experience 1968-99. Lancet 2003;15:553-560.
4. Caillat-Zucman S, Le Deist F, Haddad E, et al. Impact of HLA matching on outcome of hematopoietic stem cell transplantation in children with inherited diseases: A single center comparative analysis of genoidentical, haploidentical or unrelated donors. Bone Marrow Transplant 2004;33:1089-1095.
5. Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, et al. European Group for Blood and Marrow. Allogeneic and autologous transplantation for hematological diseases, solid tumors and immune disorders: Definitions and current practice in Europe. Bone Marrow Transplant 2006;37:439-449.
6. Myers LA, Patel DD, Puck JM, Buckley RH. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood 2002;99:872-878.
7. Stephan JL, Vlekova V, Le Deist F, et al. Severe combined immunodeficiency: A retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr 1193;123:564-572.
8. Grunebaum E, Mazzolari E, Porta F, et al. Bone marrow transplantation for severe combined immune deficiency. JAMA 2006;295:508-518.
9. Reisner Y, Martelli MF. Tolerance induction by 'megadose' transplants of CD34+ stem cells: A new option for leukemia patients without an HLA-matched donor. Curr Opin Immunol 2000;12:536-541.
10. Handgretinger R, Lang P, Ihm K, et al. Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma. Bone Marrow Transplant 2002,29:777-783.
11. Papadimitriou CA, Roots A, Koenigsmann M, et al. Immunomagnetic selection of CD34+ cells from fresh peripheral blood mononuclear cell preparations using two different separation techniques. J Hematother 1995;4:539-544.
12. McNiece I, Briddell R, Stoney G, et al. Large-scale isolation of CD34+ cells using the Amgen cell selection device results in high levels of purity and recovery. J Hematother 1997;6:5-11.
13. Dreger P, Viehmann K, Steinmann J, et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1. Exp Hematol 1995;23:147-154.
14. Arpaci F, Çetin T, Özet A, et al. The excessive numbers of total nucleated cells does not affect the performance of the CliniMACS. J Clin Apher 2004;19:197-201.
15. Urbano-Ispizua A, Rozman C, Pimentel P, et al. Spanish Group for Allogenic Peripheral Blood Transplantation. The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from HLA-identical siblings. Blood 2001;97:383-387.
16. Handgratinger R, Lang P, Schumm M, et al. Immunological aspects of haploidentical stem cell transplantation in children. Ann N Y Acad Sci 2001;938:340-357.
17. Kernan NA, Bordignon C, Heller G, et al. Graft failure after T-cell-depleted HLA identical marrow transplantation for leukemia: Analysis of risk factors and results of secondary transplants. Blood 1989;74:2227-2236.
18. Uharek L, Glass B, Gaska T, et al. Influence of donor lymphocytes on the incidence of primary graft failure after allogeneic bone marrow transplantation in a murine model. Br J Haematol 1994;88:79-87.
19. Voltarelli JC, Corpuz S, Martin PJ. In vitro comparison of two methods of T cell depletion associated with different rates of graft failure after allogeneic marrow transplantation. Bone Marrow Transplant 1990;6:419-423.
20. Buckley RH. Primary immunodeficiency diseases: Dissectors of the immune system. Immunol Rev 2002;185:206-219.
21. Klingebiel T, Handgretinger R, Lang P, et al. Haploidentical transplantation for acute lymphoblastic leukemia in childhood. Blood 2004;18:181-192.
22. Aversa F, Velardi A, Tabilio A, et al. Haploidentical stem cell transplantation in leukemia. Blood Rev 2001;15:111-119.
23. Dal-Cartivo L, Ouachee-Chardin, Hirsch I, et al. Does haploidentical transplantation in children with primary immunodeficiencies have the potential to exploit donor NK cell alloreactivity? Bone Marrow Transplant 2004;34:945-947.
24. Przepiorka D, Weisdorf D, Martin P, et al. Consensus conference on acute GvHD grading. Bone Marrow Transplant 1995;15:825-28.
25. Bearman SI, Appelbaum FR, Buckner CD, et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988;6:1562-1568.